Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Seminars in Oncology|July 16, 2014
Platelets promote liver immunopathology contributing to hepatitis B virus-mediated hepatocarcinogenesisGiovanni SitiaCellular & Molecular Immunology|January 13, 2015
Chronic hepatitis B: role of anti-platelet therapy in inflammation controlRoberto Aiolfi, Giovanni SitiaJournal of Hepatocellular Carcinoma|August 11, 2016
Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinomaRoberto Aiolfi, Giovanni SitiaJournal of Hepatology|June 8, 2013
Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinomaGiovanni Sitia, Matteo Iannacone, Luca G GuidottiJournal of Hepatology|February 24, 2007
HBV pathogenesis in animal models: recent advances on the role of plateletsMatteo Iannacone, Giovanni Sitia, Zaverio M Ruggeri, et al.Journal of Leukocyte Biology|August 29, 2006
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic miceGiovanni Sitia, Matteo Iannacone, Susanne Müller, et al.Gels (Basel, Switzerland)|January 14, 2021
Advances in Bio-Based Polymers for Colorectal CancerTreatment: Hydrogels and NanoplatformsAnna Maspes, Fabio Pizzetti, Arianna Rossetti, et al.Clinical and Vaccine Immunology : CVI|September 21, 2007
Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirusMatteo Iannacone, Giovanni Sitia, Iñigo Narvaiza, et al.Current Oncology (Toronto, Ont.)|December 24, 2025
STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor SignalingJorge Canar, Madeline Bono, Amy Alvarado, et al.Science Signaling|February 22, 2022
Arenaviral infection causes bleeding in mice due to reduced serotonin release from plateletsRoberto Aiolfi, Giovanni Sitia, Matteo Iannacone, et al.Pageof 5